InvestorsObserver
×
News Home

Will Amgen, Inc. (AMGN) Stay at the Top of the Healthcare Sector?

Wednesday, June 22, 2022 03:41 PM | InvestorsObserver Analysts

Mentioned in this article

Will Amgen, Inc. (AMGN) Stay at the Top of the Healthcare Sector?

Amgen, Inc. (AMGN) is around the top of the Healthcare sector according to InvestorsObserver. AMGN received an overall rating of 74, which means that it scores higher than 74% of stocks. Additionally, Amgen, Inc. scored a 84 in the Healthcare sector, ranking it higher than 84% of stocks in that sector.

Overall Score - 74
AMGN has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on AMGN!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 74 would rank higher than 74 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Amgen, Inc. Stock Today?

Amgen, Inc. (AMGN) stock is trading at $240.83 as of 3:25 PM on Wednesday, Jun 22, a gain of $2.42, or 1.02% from the previous closing price of $238.41. The stock has traded between $236.90 and $242.34 so far today. Volume today is below average. So far 2,375,495 shares have traded compared to average volume of 3,543,690 shares. Click Here to get the full Stock Report for Amgen, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App